#Europe

Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.

The Mosaico study will enroll gay and bisexual men and transgender people at significant risk for the virus.

On-demand PrEP is taken only during the days surrounding sex.

Researchers conducted an analysis of hep C treatment outcomes in those also living with HIV in Western nations.

Traditionally hep C transmits sexually mostly among HIV-positive men who have sex with men.

Italian researchers randomized half of a group of people on daily Atripla to switch to taking the single-tablet regimen every second day.

Researchers analyzed data on people living with HIV in the United Kingdom, Ireland and the Netherlands.

However, this finding applied only to those in low- and middle-income nations.

Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.

Researchers believe that hepatitis C is spreading through sex from the HIV-positive population to those who don’t have HIV.

A decade of aging brings on heart and kidney troubles in people with HIV.

Research indicates that Retrovir, Zerit and Videx are associated with abnormal redistribution of body fat.

A European study of nearly 19,000 people with HIV also found that curing hep C was not associated with heart disease or non-AIDS cancer.

The Conference on Retroviruses and Opportunistic Infections in Seattle saw many important studies that are advancing the fight against HIV.

HIV-positive men who have sex with men in Western nations historically have a significant risk of contracting hepatitis C through sex.

“The Düsseldorf Patient” has been off HIV meds only since November 2018, so it is much too early to determine whether he has been cured.